Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Gene Therapy for Inherited Genetic Disorders market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gene Therapy for Inherited Genetic Disordersmarket, defines the market attractiveness level of Gene Therapy for Inherited Genetic Disorders market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gene Therapy for Inherited Genetic Disorders industry, describes the types of Gene Therapy for Inherited Genetic Disorders market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gene Therapy for Inherited Genetic Disorders market and the development prospects and opportunities of Gene Therapy for Inherited Genetic Disorders industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gene Therapy for Inherited Genetic Disorders market in Chapter 13.
By Player:
Spark Therapeutics Inc
Novartis AG
BioMarin Pharmaceutical Inc
Orchard Therapeutics Plc
bluebird bio Inc
By Type:
Eye Disorders
Hematological Disorders
Central Nervous System Disorders
Muscular Disorders
Others
By End-User:
Hospital
Clinic
Research Institute
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gene Therapy for Inherited Genetic Disorders Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gene Therapy for Inherited Genetic Disorders Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gene Therapy for Inherited Genetic Disorders Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gene Therapy for Inherited Genetic Disorders Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gene Therapy for Inherited Genetic Disorders Market Analysis and Outlook to 2022
-
7.1 Global Gene Therapy for Inherited Genetic Disorders Consumption (2017-2022)
-
7.2 United States Gene Therapy for Inherited Genetic Disorders Consumption (2017-2022)
-
7.3 Europe Gene Therapy for Inherited Genetic Disorders Consumption (2017-2022)
-
7.4 China Gene Therapy for Inherited Genetic Disorders Consumption (2017-2022)
-
7.5 Japan Gene Therapy for Inherited Genetic Disorders Consumption (2017-2022)
-
7.6 India Gene Therapy for Inherited Genetic Disorders Consumption (2017-2022)
-
7.7 South Korea Gene Therapy for Inherited Genetic Disorders Consumption (2017-2022)
8 Region and Country-wise Gene Therapy for Inherited Genetic Disorders Market Analysis and Outlook to 2028
-
8.1 Global Gene Therapy for Inherited Genetic Disorders Consumption Forecast (2022-2028)
-
8.2 United States Gene Therapy for Inherited Genetic Disorders Consumption Forecast (2022-2028)
-
8.3 Europe Gene Therapy for Inherited Genetic Disorders Consumption Forecast (2022-2028)
-
8.4 China Gene Therapy for Inherited Genetic Disorders Consumption Forecast (2022-2028)
-
8.5 Japan Gene Therapy for Inherited Genetic Disorders Consumption Forecast (2022-2028)
-
8.6 India Gene Therapy for Inherited Genetic Disorders Consumption Forecast (2022-2028)
-
8.7 South Korea Gene Therapy for Inherited Genetic Disorders Consumption Forecast (2022-2028)
9 Global Gene Therapy for Inherited Genetic Disorders Market Outlook by Types and Applications to 2022
-
9.1 Global Gene Therapy for Inherited Genetic Disorders Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Eye Disorders Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Hematological Disorders Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Central Nervous System Disorders Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Muscular Disorders Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Gene Therapy for Inherited Genetic Disorders Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Institute Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Gene Therapy for Inherited Genetic Disorders Market Outlook by Types and Applications to 2028
-
10.1 Global Gene Therapy for Inherited Genetic Disorders Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Eye Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Hematological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Central Nervous System Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Muscular Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gene Therapy for Inherited Genetic Disorders Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research Institute Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Gene Therapy for Inherited Genetic Disorders Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gene Therapy for Inherited Genetic Disorders Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gene Therapy for Inherited Genetic Disorders Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gene Therapy for Inherited Genetic Disorders Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gene Therapy for Inherited Genetic Disorders Market Competitive Analysis
-
14.1 Spark Therapeutics Inc
-
14.1.1 Spark Therapeutics Inc Company Details
-
14.1.2 Spark Therapeutics Inc Gene Therapy for Inherited Genetic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Spark Therapeutics Inc Gene Therapy for Inherited Genetic Disorders Product and Service
-
14.2 Novartis AG
-
14.2.1 Novartis AG Company Details
-
14.2.2 Novartis AG Gene Therapy for Inherited Genetic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis AG Gene Therapy for Inherited Genetic Disorders Product and Service
-
14.3 BioMarin Pharmaceutical Inc
-
14.3.1 BioMarin Pharmaceutical Inc Company Details
-
14.3.2 BioMarin Pharmaceutical Inc Gene Therapy for Inherited Genetic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 BioMarin Pharmaceutical Inc Gene Therapy for Inherited Genetic Disorders Product and Service
-
14.4 Orchard Therapeutics Plc
-
14.4.1 Orchard Therapeutics Plc Company Details
-
14.4.2 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product and Service
-
14.5 bluebird bio Inc
-
14.5.1 bluebird bio Inc Company Details
-
14.5.2 bluebird bio Inc Gene Therapy for Inherited Genetic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 bluebird bio Inc Gene Therapy for Inherited Genetic Disorders Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gene Therapy for Inherited Genetic Disorders
-
Figure Gene Therapy for Inherited Genetic Disorders Picture
-
Table Global Gene Therapy for Inherited Genetic Disorders Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene Therapy for Inherited Genetic Disorders Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene Therapy for Inherited Genetic Disorders Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gene Therapy for Inherited Genetic Disorders Consumption by Country (2017-2022)
-
Figure United States Gene Therapy for Inherited Genetic Disorders Consumption and Growth Rate (2017-2022)
-
Table Europe Gene Therapy for Inherited Genetic Disorders Consumption and Growth Rate (2017-2022)
-
Figure China Gene Therapy for Inherited Genetic Disorders Consumption and Growth Rate (2017-2022)
-
Figure Japan Gene Therapy for Inherited Genetic Disorders Consumption and Growth Rate (2017-2022)
-
Figure India Gene Therapy for Inherited Genetic Disorders Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gene Therapy for Inherited Genetic Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Therapy for Inherited Genetic Disorders Consumption Forecast by Country (2022-2028)
-
Figure United States Gene Therapy for Inherited Genetic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gene Therapy for Inherited Genetic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gene Therapy for Inherited Genetic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gene Therapy for Inherited Genetic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gene Therapy for Inherited Genetic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gene Therapy for Inherited Genetic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Eye Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Hematological Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Central Nervous System Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Muscular Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institute Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Eye Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hematological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Central Nervous System Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Muscular Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institute Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gene Therapy for Inherited Genetic Disorders Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gene Therapy for Inherited Genetic Disorders Export by Region (Top 5 Countries) (2017-2028)
-
Table Spark Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Spark Therapeutics Inc Gene Therapy for Inherited Genetic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spark Therapeutics Inc Gene Therapy for Inherited Genetic Disorders Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Gene Therapy for Inherited Genetic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Gene Therapy for Inherited Genetic Disorders Product and Service
-
Table BioMarin Pharmaceutical Inc (Foundation Year, Company Profile and etc.)
-
Table BioMarin Pharmaceutical Inc Gene Therapy for Inherited Genetic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioMarin Pharmaceutical Inc Gene Therapy for Inherited Genetic Disorders Product and Service
-
Table Orchard Therapeutics Plc (Foundation Year, Company Profile and etc.)
-
Table Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product and Service
-
Table bluebird bio Inc (Foundation Year, Company Profile and etc.)
-
Table bluebird bio Inc Gene Therapy for Inherited Genetic Disorders Sales, Price, Value and Gross Profit (2017-2022)
-
Table bluebird bio Inc Gene Therapy for Inherited Genetic Disorders Product and Service
-
